La prise en charge de l'hépatite B

II.6. Références

1. Albin C, Robinson WS. Protein kinase activity in hepatitis B virus. J Virol., 1980 ; 34: 297- 302

2. Bayer ME, Blumberg BS, Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's syndrome and hepatitis. Nature., 1968 ; 218:1057-9

3. Blumberg BS, Gerstley BJ, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med, 1967 ; 66 (5):924-31

4. Blumberg BS. Australia antigen and the biology of hepatitis B. Science, 1977 ; 197 (4298):17-25

5. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G: Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998, 27:254-263.

6. Blum HE, Galun E, Liang TJ, von Weizsacker F, Wands JR: Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991, 65:1836-1842.

7. BLACQUE-BELAIR, A, 1981, Dictionnaire Médical clinique - Pharmacologique et Thérapeutique .In : Hépatite viral, 3éme éd, Paris, (833-837) p.

8. Bremer CM, Bung C, Kott N, Hardt M, Glebe D. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbio., 2009 ; 11 (2): 249-60

9. Bruss V, Hepatitis B virus morphogenesis. World J Gastroenterol., 2007 ; 13 (1): 65-73

10. Blumberg BS, Alter HJ, Visnich S. A «new» antigen in leukemia sera. JAMA, 1965 ; 191(7): 514-6

11. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336:325-329.

12. CATIE- La source canadienne de renseignements sur le VIH et l'hépatite C

https:// www .catie.ca/fr/lhepatite-b

13. CHEVROT.M, Phosphatase alcaline, Laboratoire de biochimie, Groupe hospitalier Pitié-Salpêtrière, Paris, France, 2017, Disponible sur : < https://www.em-consulte.com/article/65797/phosphatase-alcaline >. [page consultée le 21/06/2020].

14. Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet., 1970 ; 1 (7649):695-8

15. Dény P, Zoulim F. Hepatitis B virus: from diagnosis to treatment. Pathol Biol. , 2010 ; 58 (4):245-53

16. Desmyter J, De Groote J, Desmet VJ, Billiau A, Ray MB, Bradburne AF, Edv VG, De Somer P. Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet., 1976 ; 2 (7987):645-7

17. Epidémiologie de l'Hépatite B (hepatoweb.com)

18. Francois G, Kew M, Van Damme P, Mphahlele MJ, Meheus A: Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 2001, 19:3799- 3815

19. FOUET.P, 1978, Abrégé d'hépatologie, 1erTrim-MASSON, Paris (France), (29-30)p.

20. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. Coli. Nature., 1979, 281 (5733): 646-50

21. GUIDE DE GESTION DU PROGRAMME ELARGI DE VACCINATION ET DE LA SURVEILLANCE EPIDEMIOLOGIQUE, Juin 2013 Ministère de sante Sénégal

22. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol., 1984 ; 52 (2):396- 402

23. Hépatite B : Réponses SST (cchst.ca)

24. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Research., 2007 ; 127: 164-76.

25. Korba BE, Brown TL, Wells FV, Baldwin B, Cote PJ, Steinberg H, Tennant BC, Gerin JL. Natural history of experimental woodchuck hepatitis virus infection: molecular

virologic features of the pancreas, kidney, ovary and testis. J Virol., 1990 ; 64 (9): 4499-506

26. Kim WR, Ishitani MB, Dickson ER. Rising burden of hepatitis B in the United States: should the other virus beforgotten? 53rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 1-5, 2002. Boston,MA. Hepatology 2002; 36, 4(2) Abstract A-223.

27. Liaw YF et al. Resultat of lamivudine trials in Asia. J Hepatol 2003; 39: 111-115.

28. Mangold CM, Unckell F, Werr M, Streeck RE. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology., 1995 ; 211 (2): 535-43

29. Marta N, HEPATITE B : ETUDE EPIDEMIOLOGIQUE, Mémoire en vue de l'obtention du Diplôme Inter-Universitaire International de Vaccinologie, UCAD, 2018.

30. Marcellin P, Asselah T, Boyer N. Traitement de l'Hépatite Chronique B. Revu Prat 2005 ; 55 : 624-632.

31. Maupas P, Goudeau A, Coursaget P, Drucker J, Bagros P. Immunisation against hepatitis B in man. Lancet., 1976 ; 1 (7974): 1367-70

32. MacCallum F. Homologous serum hepatitis. Lancet., 1947 ; 2:691-2

33. Mme Fatima B, La séroprévalence de l'hépatite virale B dans la région de Marrakech, pour l'obtention du doctorat en médecine, CADI AYYAD, 2016

34. M. Idrissa B, Etude de la réponse vaccinale contre l'hépatite B chez les enfants âgé de 3 mois a 6 ans suivis à l'hôpital des enfants Albert Royer, Université Cheik Anta Diop DakarHepatocellular carcinoma and type B hepatitis.

35. Mondellh A, Evolution de la prise en charge de l'hépatite B en Afrique subsaharienne : enjeux et perspective, Université Toulouse III Paul Sabatier, 2014

36. Nebbia G, Peppa D, Maini MK Hepatitis B infection: current concepts and future challenges. Q J Med, 2012 ; 105:109-13

37. Organisation Mondiale de la Santé. [En ligne] 27 JUILLET 2020. www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b.

38. Pawlotsky JM: The concept of hepatitis B virus mutant escape. J Clin Virol 2005, 34 Suppl 1:S125- 129.

39. Pol S. Histoire naturelle de l'infection par le virus de l'hepatite B. La Presse Médicale., 2006 ; 35:308-16

40. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G: Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998, 27:254-263.

41. Robinson WS, Clayton DA, Greenman RL. DNA of a human hepatitis B virus candidate. J Virol., 1974 ; 14 (2):384-91

42. Schaefer S, Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol., 2007 ; 13 (1): 14-21

43. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev., 2000 ; 64 (1):51- 68

44. SENEGAL : Programme National de Lutte contre les Hépatites - Les chiffres (hepatites.sn)

45. Summers J, Mason WS. Replication of the genome of à hepatitis-B like virus by reverse transcription of an RNA intermediate. Cell., 1982 ; 29 (2): 403-15

46. Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U.S.A., 1978 ; 75 (9): 4533-7

47. Tong SP, Li JS, Vitvitski L, Kay A, Treepo C: Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J Virol 1993, 67:5651-5655.

48. Trepo C. A brief history of hepatitis milestones. Liver Int., 2014 ; 34 Suppl 1: 29-37

49. VIDAL, La transmission de l'hépatite B.

https://www.vidal.fr/maladies/estomac-intestins/hepatite-b/causes.html?msclkid=33a9e1cca63511ecb542557f40c4b157

50. Weber B: Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005, 32:102-112.